Publication:
Synthesis and Anti-Inflammatory Activities of Novel 5-(3,4-Dichlorophenyl)-3-[(4-Substitutedpiperazin-1-yl)methyl]-1,3,4-Oxadiaxole-2(3H)-Thiones

dc.authorscopusid7003772860
dc.authorscopusid57218163778
dc.authorscopusid55832004400
dc.authorscopusid35561472800
dc.contributor.authorKöksal, M.
dc.contributor.authorYuksel, M.
dc.contributor.authorErdal, A.
dc.contributor.authorBozkurt, A.
dc.date.accessioned2020-06-21T09:37:28Z
dc.date.available2020-06-21T09:37:28Z
dc.date.issued2014
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Köksal] Meriç, Department of Pharmaceutical Chemistry, Yeditepe University, Istanbul, Turkey; [Yuksel] Mine Yarim, Department of Pharmaceutical Chemistry, Yeditepe University, Istanbul, Turkey; [Erdal] Arzu, Department of Pharmacology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Bozkurt] Ayhan, Department of Physiology, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractPurpose: To synthesize a new series of 5-(3,4-dichlorophenyl)-3-[(4- substitutedpiperazin-1-yl)methyl]-1,3,4-oxadiaxole-2-thiones for their anti-inflammatory activity. Methods: The title compounds synthesized by Mannich reaction of prepared 5-(3,4-dichloroÂphenyl)-1,3,4-oxadiazole-2-thione and appropriate substituted piperazine derivatives. The structures of the compounds were confirmed by IR, NMR and elemental analyses. The newly synthesized compounds were evaluated for their anti-inflammatory and ulcerogenic activities. Results: Most of the compounds were found to have significant anti-inflammatory profile in carrageenan footpad edema test. The compounds showed anti-inflammatory activity ranging from 30.6% to 57.8% inhibition. Conclusion: The compounds 5b, 5f, 5i, 5p and 5r showed most prominent anti-inflammatory activity with low gastric ulceration incidence than the reference drug indomethacine. These compounds could serve as lead molecules for further modifications. © Georg Thieme Verlag KG Stuttgart, New York.en_US
dc.identifier.doi10.1055/s-0033-1353184
dc.identifier.endpage72en_US
dc.identifier.issn2194-9379
dc.identifier.issn2194-9387
dc.identifier.issue2en_US
dc.identifier.pmid23986309
dc.identifier.scopus2-s2.0-84893874632
dc.identifier.scopusqualityQ3
dc.identifier.startpage66en_US
dc.identifier.urihttps://doi.org/10.1055/s-0033-1353184
dc.identifier.volume64en_US
dc.language.isoenen_US
dc.relation.ispartofDrug Researchen_US
dc.relation.journalDrug Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject1,3,4-Oxadiazole-2-Thionesen_US
dc.subjectAnti-Inflammatory Drugsen_US
dc.subjectGastric Ulcerationen_US
dc.subjectPiperazineen_US
dc.titleSynthesis and Anti-Inflammatory Activities of Novel 5-(3,4-Dichlorophenyl)-3-[(4-Substitutedpiperazin-1-yl)methyl]-1,3,4-Oxadiaxole-2(3H)-Thionesen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files